DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depacon (Valproate Sodium) - Published Studies

 
 



Depacon Related Published Studies

Well-designed clinical trials related to Depacon (Valproate)

Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial. [2014]

Assessment of cognitive impairments and seizure characteristics in electroconvulsive therapy with and without sodium valproate in manic patients. [2013]

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. [2013]

Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. [2013]

Assessment of cognitive impairments and seizure characteristics in electroconvulsive therapy with and without sodium valproate in manic patients. [2013]

Comparing efficacy of ECT with and without concurrent sodium valproate therapy in manic patients. [2012]

A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis. [2012]

Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. [2011.12]

Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. [2011.10]

Magnesium valproate in learning disabled children with interictal paroxysmal EEG patterns: Preliminary report. [2011.04.01]

Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. [2011.03]

Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. [2011.03]

Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. [2011.02]

Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study. [2011]

A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression. [2011]

Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. [2011]

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results. [2010.10.08]

A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. [2010.08.01]

Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study. [2010.06]

Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial. [2010.06]

Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. [2010.04]

Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study. [2010.03]

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. [2010.03]

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. [2010.01.30]

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. [2010.01.30]

Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial. [2010]

A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. [2010]

Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study. [2010]

Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial. [2010]

Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. [2009.12]

A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. [2009.09]

Comparison of treatment effect of sodium valproate, propranolol and tricyclic antidepressants in migraine. [2009.08.01]

Valproate preparations for agitation in dementia. [2009.07.08]

Valproate treatment and cocaine cue reactivity in cocaine dependent individuals. [2009.06.01]

A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive. [2009.06]

Lamotrigine and valproate pharmacokinetics interactions in epileptic patients. [2009.04]

Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study. [2009.04]

Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. [2009.03.10]

Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. [2009.03]

Comparison of add-on valproate and primidone in carbamazepine-unresponsive patients with partial epilepsy. [2009.03]

[Open randomized comparative twelve-week study of lithium and valproate in manic episode] [2009]

Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. [2008.12]

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. [2008.10]

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. [2008.09]

Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. [2008.08]

Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. [2008.04]

Valproate-induced thrombocytopenia: a prospective monotherapy study. [2008.03]

Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study. [2008.03]

The effect of sodium valproate on chronic daily headache and its subgroups. [2008.02]

The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. [2007.12]

Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. [2007.10]

Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study. [2007.10]

Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized open-label comparison. [2007.06]

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]

Safety of rapid intravenous valproate infusion in pediatric patients. [2007.02]

A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease. [2007]

Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures. [2006.11.28]

Sodium valproate vs phenytoin in status epilepticus: a pilot study. [2006.07.25]

Inositol augmentation of lithium or valproate for bipolar depression. [2006.04]

Modulation of serum concentrations of melatonin by carbamazepine and valproate. [2006.01]

Valproate attenuates dextroamphetamine-induced subjective changes more than lithium. [2005.12]

Efficacy of topiramate and valproate in chronic migraine. [2005.11]

A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. [2005.08]

Differential effects of chronic lithium and valproate on brain activation in healthy volunteers. [2005.08]

A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence. [2005.03]

Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation. [2005.03]

Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration. [2005.01]

Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks. [2005.01]

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. [2005.01]

Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. [2004.12]

A randomized, double-blind, placebo controlled trial of melatonin add-on therapy in epileptic children on valproate monotherapy: effect on glutathione peroxidase and glutathione reductase enzymes. [2004.11]

Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. [2004.08]

The prophylactic effect of valproate on glyceryltrinitrate induced migraine. [2004.07]

Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial. [2004.06]

The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers. [2004.04]

Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. [2004.02]

Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. [2004.01]

Effect of valproate on hemostatic function in patients with traumatic brain injury. [2003.12]

Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. [2003.12]

Valproate therapy for agitation in dementia: open-label extension of a double-blind trial. [2003.07]

Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. [2003.06]

Differential cognitive and behavioral effects of topiramate and valproate. [2003.05.13]

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. [2003.03]

Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial. [2003.02]

Safety and tolerance of rapidly infused Depacon. A randomized trial in subjects with epilepsy. [2003.01]

Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. [2002.11]

A pilot study of loading versus titration of valproate in the treatment of acute mania. [2002.10]

Lithium and valproate treatment of pathological gambling: a randomized single-blind study. [2002.07]

Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial. [2002.06]

Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. [2002.01]

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. [2002.01]

Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. [2001.11]

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. [2001.01.23]

Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. [2001]

[Effectiveness, safety and practicality of delayed-release minitablets of valproate in bipolar affective disorders] [2000.11]

Can sodium valproate improve learning in children with epileptiform bursts but without clinical seizures? [2000.11]

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. [2000.09]

Study on the dose proportionality of the pharmacokinetics of sustained release sodium valproate. [2000.08]

Weight gain associated with valproate in childhood. [2000.05]

Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. [2000.04]

Neuropsychological effects of valproate in traumatic brain injury: a randomized trial. [2000.02.22]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017